The MSL role has become more strategic as the frontline agent for KOL engagement. KOL expectations have also increased in terms of what they are looking for from biopharma partnerships. The trend toward personalized engagement has accelerated significantly due to rapid digital transformation and hybrid engagement advancements in recent years across life science companies. … [Read more...]
Leveraging an Outcome-Based RWE Framework to Further Quantify Field Medical Value
The MSL role has gained significant importance in the life science industry and is becoming -critical in terms of KOL engagement. However, the value of field medical activities has not always been easily quantifiable in terms of traditional business impact due to the primary focus on scientific and clinical exchange with target physicians. We can take a chapter out of the … [Read more...]